These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1555 related items for PubMed ID: 17402564

  • 1. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y.
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [Abstract] [Full Text] [Related]

  • 2. Prospects for nanomedicine in treating age-related macular degeneration.
    Tamaki Y.
    Nanomedicine (Lond); 2009 Apr; 4(3):341-52. PubMed ID: 19331541
    [Abstract] [Full Text] [Related]

  • 3. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL.
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [Abstract] [Full Text] [Related]

  • 4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ, Terada Y, Haddadin MJ, Michaud NA, Gragoudas ES, Miller JW.
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH.
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [Abstract] [Full Text] [Related]

  • 6. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer.
    Ideta R, Tasaka F, Jang WD, Nishiyama N, Zhang GD, Harada A, Yanagi Y, Tamaki Y, Aida T, Kataoka K.
    Nano Lett; 2005 Dec; 5(12):2426-31. PubMed ID: 16351191
    [Abstract] [Full Text] [Related]

  • 7. [Novel gene transfer using micellar nanovectors inhibits choroidal neovascularization].
    Aoki A.
    Nippon Ganka Gakkai Zasshi; 2013 Nov; 117(11):869-77. PubMed ID: 24397183
    [Abstract] [Full Text] [Related]

  • 8. Subretinal transplantation of retinal pigment epithelium overexpressing fibulin-5 inhibits laser-induced choroidal neovascularization in rats.
    Li F, Zeng Y, Xu H, Yin ZQ.
    Exp Eye Res; 2015 Jul; 136():78-85. PubMed ID: 25983185
    [Abstract] [Full Text] [Related]

  • 9. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
    Huang Y, Xu G, Peng Y, Lin H, Zheng X, Xie M.
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
    [Abstract] [Full Text] [Related]

  • 10. Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration.
    Donati G, Kapetanios AD, Pournaras CJ.
    Semin Ophthalmol; 1999 Mar; 14(1):2-10. PubMed ID: 10790570
    [Abstract] [Full Text] [Related]

  • 11. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N, Ranjbar M, Evers C, Hua J, Martin G, Schulze B, Michaelis U, Hansen LL, Agostini HT.
    Mol Vis; 2013 Mar; 19():54-61. PubMed ID: 23335851
    [Abstract] [Full Text] [Related]

  • 12. Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats.
    Ideta R, Yanagi Y, Tamaki Y, Tasaka F, Harada A, Kataoka K.
    FEBS Lett; 2004 Jan 16; 557(1-3):21-5. PubMed ID: 14741335
    [Abstract] [Full Text] [Related]

  • 13. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
    Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T.
    Invest Ophthalmol Vis Sci; 2001 Oct 16; 42(11):2639-45. PubMed ID: 11581211
    [Abstract] [Full Text] [Related]

  • 14. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
    She H, Nakazawa T, Matsubara A, Hisatomi T, Young TA, Michaud N, Connolly E, Hafezi-Moghadam A, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 2007 May 16; 48(5):2268-77. PubMed ID: 17460290
    [Abstract] [Full Text] [Related]

  • 15. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.
    Lange N, Ballini JP, Wagnieres G, van den Bergh H.
    Invest Ophthalmol Vis Sci; 2001 Jan 16; 42(1):38-46. PubMed ID: 11133846
    [Abstract] [Full Text] [Related]

  • 16. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD].
    Pauleikhoff D, Bornfeld N, Gabel VP, Holz F, Roider H, German Ophthalmological Society, Retinological Society, Professional Association of Ophthalmologists.
    Klin Monbl Augenheilkd; 2005 May 16; 222(5):381-8. PubMed ID: 15912454
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A, Ming Y, Kvanta A.
    Curr Eye Res; 2006 Sep 16; 31(9):765-74. PubMed ID: 16966149
    [Abstract] [Full Text] [Related]

  • 18. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
    Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T.
    Arch Ophthalmol; 2000 May 16; 118(5):650-8. PubMed ID: 10815157
    [Abstract] [Full Text] [Related]

  • 19. Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization.
    She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim I, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 2008 Nov 16; 49(11):5008-14. PubMed ID: 18421085
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad.
    Framme C, Sachs HG, Kobuch K, Flucke B, Birngruber R.
    Ophthalmologica; 2008 Nov 16; 222(4):254-64. PubMed ID: 18525218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.